Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

Guidance Statements 9 and 10 that were published in the 2018 Practice Guidance on primary biliary cholangitis (PBC) have been revised.[1] This American Association for the Study of Liver Diseases 2021 practice guidance on PBC is a focused update of the PBC guidance published in 2018. The major changes from the last guidance to this guidance include information about obeticholic acid (OCA). In May 2021, the Food and Drug Administration issued a...